Consortia

The Accelerating Medicine Partnership in Parkinson’s Disease and Related Disorders (AMP® PDRD) is a public-private partnership between the National Institutes of Health (NIH), multiple biopharmaceutical and life science companies, and nonprofit organizations. Managed through the Foundation for the NIH (FNIH), AMP® PDRD aims to harmonize Parkinson’s and related disease datasets across the community with the goal of identifying and validating diagnostic, prognostic, and/or progression biomarkers for Parkinson’s disease, with an emphasis on broadening data sharing in the biomedical community to advance Parkinson’s research. ASAP is proud to be a partner in the AMP® PDRD effort to broaden data sharing in the biomedical community to advance Parkinson’s research. Both GP2 and PPMI cohorts share their data on this platform.

ASAP is proud to join alongside philanthropic organizations as a member of The Open Research Funders Group (ORFG). ORFG is a partnership of funding organizations committed to the open sharing of research outputs and other forms of scholarship. The ORFG has two primary programmatic pillars: (1) engaging philanthropies in a community of practice to develop, implement, oversee, and advance strategies that accelerate access to funded research, including papers and data; and (2) serving as the funders’ voice in cross-sector discussions about open research policies, incentives, infrastructure, and good practices.

ASAP is a proud member of Plan S, an initiative for Open Access publishing. The plan is supported by cOAlition S, an international consortium of research funding and performing organizations. Plan S requires that, from 2021, scientific publications that result from research funded by public grants must be published in compliant Open Access journals or platforms.

ASAP is proud to join the Research Software Alliance (ReSA) as an organizational member. ReSA is dedicated to advancing the research software ecosystem by collaborating with decision-makers and key influencers.